Skip to main content

Advertisement

Log in

Gas6, warfarin, and kidney diseases

  • REVIEW ARTICLE
  • Published:
Journal of Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

The product of growth arrest-specific gene 6 (Gas6) is a unique vitamin K-dependent autocrine growth factor for mesangial cells, and warfarin inhibits mesangial cell proliferation by interfering with the activation process of Gas6. A recent series of studies has revealed the in vivo roles of Gas6 and its receptor Axl in the progression of acute and chronic glomerulonephritis, diabetic nephropathy, chronic allograft rejection, and human kidney diseases. This review summarizes these studies and discusses the possible interventions targeting the Gas6/Axl pathway to prevent the progression of kidney diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Motoko Yanagita.

About this article

Cite this article

Yanagita, M. Gas6, warfarin, and kidney diseases. Clin Exp Nephrol 8, 304–309 (2004). https://doi.org/10.1007/s10157-004-0305-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-004-0305-z

Key words

Navigation